Transmission of SARS-CoV-2, the causative agent of COVID-19, occurs primarily through respiratory droplets in close contact settings or by airborne transmission in poorly ventilated enclosed spaces. 1 Contact transmission, also known as fomite transmission, occurs through contact with contaminated materials or surfaces. Personal protective equipment (PPE) worn by healthcare providers is exposed to SARS-CoV-2 while caring for infectious patients, in turn increasing the chances of fomite transmission of the virus during PPE doffing or reuse without prior disinfection. Certain high-risk airway procedures such as intubation or suctioning have the potential to produce large amounts of phlegm, mucus, and/or saliva, in addition to aerosols. 2 Thus, PPE worn by healthcare workers when performing these or similar procedures are exposed to higher virus concentrations than those worn during lower-risk medical procedures not involving the patient’s airway. 3 Herein, we carried out a pilot study to model the stability of SARS-CoV-2 on common PPE worn in hospitals to simulate a moderate-dose SARS-CoV-2 transmission event that might occur during a high-risk airway procedure on a COVID-19 patient.
Evaluated materials comprised 6.3 mm2 of selected PPE (Table 1). We also evaluated 50/50 nylon/cotton ripstop fabric treated with insect shield (permethrin 0.5% [%W/W]: Tullahoma Industries, LLC, Tullahoma, TN). All materials were surface disinfected by ultraviolet (UV) light for 10 minutes, after which they were contained within covered six-well cell culture plates to mimic PPE storage, and incubated at 22 ± 2°C with a relative humidity of 40–50% in an operating class II biosafety cabinet throughout the duration of the experiment. Triplicate samples of each material were exposed to 50 µL of SARS-CoV-2 (USA-WA1/2020, GenBank accession no. MN985325.1), with the challenge dose being 4.3 log10 plaque-forming units (PFUs). This dose was selected based on reported viral RNA loads in sputum of human clinical samples. 4 Samples were collected at 4, 8, 24, 48, and 72 hours postexposure. A 72-hour time frame was selected as it coincides with a common work schedule observed by many intensive care unit personnel (e.g., nurses) in the United States (three 12-hour shifts worked over three consecutive days of the week) who may need to reuse PPE day after day because of PPE shortages. Forceps were used to collect samples and place them into 2 mL tubes containing media as previously described, 5 after which forceps were disinfected between samples using 5% MicroChem™ Plus followed by 70% ethanol. Samples were then stored at −80°C before quantification of infectious virus. Virus titration was performed in duplicate via plaque assay on Vero 76 cells (ATCC, Manassas, VA; CRL-1587) as previously described, 5 with the limit of detection being 1.0 log10 PFU/mL.
Personnel protective equipment evaluated and associated geometric mean half-life in hours by material
|Product||Manufacturer||Material||Material description||Geometric mean half-life* (95% CI)|
|3M Versaflo economy hood||3M (Cat No. S-403)||Visor||Polyethylene terephthalate glycol||10.05 (9.496–10.642)|
|Shroud fabric||Polypropylene-coated nonwoven polypropylene||9.12 (8.444–9.858)|
|ILC Dover SENTINEL XL BioShield full hood||ILC Dover (Cat No. S-2028)||Visor||Optically clear polyester||8.72 (7.615–9.981)|
|Shroud fabric||Spunbound polypropylene nonwoven with a polyethylene outer film||6.74 (5.639–8.051)|
|FisherBrand disposable full face shield antifog||ThermoFisher Scientific (Cat No. 19-460-102)||Visor||Polyester treated with an antifog and antistatic coating||8.83 (7.383–10.554)|
|DuPont Tyvek 400 coverall||DuPont (Cat No. TY127SWH)||Fabric||DuPont Tyvek 400||9.08 (7.635–10.802)|
Half-lives were estimated by fitting a Poisson regression to each sample, and t-statistic CIs were computed on the log half-lives. Predicted mean titers were based on an over-dispersed Poisson generalized estimating equation. Analyses were implemented in SAS version 9.4 (SAS Institute Inc., Cary, NC).
We found an inverse relationship between SARS-CoV-2 stability on material surfaces and time (Figure 1), as reported in previous studies. 5–15 At 72 hours postexposure, all PPE materials had similar detectable titers, with the exception of the 3M™ Versaflo™ economy hood (shroud fabric), Saint Paul, MN, which had a titer of 1.1 log10 PFU/mL. By 72 hours postexposure, all materials displayed a reduction in titer ≥ 4.29 log10, with final titers of 2.3 log10 PFU/mL (3M Versaflo economy hood visor), 1.9 log10 PFU/mL (ILC Dover SENTINEL XL® BioShield full hood visor, ILC Dover, Frederica, DE), 2.2 log10 PFU/mL (FisherBrand® disposable full face shield antifog, ThermoFisher Scientific, Waltham, MA), 2.1 log10 PFU/mL (3M Versaflo economy hood shroud fabric), and 2.1 log10 PFU/mL (DuPont™ Tyvek® 400 Coverall, Midland, MI). The geometric mean half-life of all PPE materials varied from between 6.74 and 10.05 hours (Table 1 and Supplemental Figure 1), with the ILC Dover SENTINEL XL® BioShield full hood visor and shroud fabric displaying the shortest half-life. Viable virus on the Insect Shield treated 50/50 nylon/cotton ripstop fabric decreased rapidly, 2.8 log10 PFU/mL at 4 hours postexposure, and 2.1 log10 PFU/mL at 8 hours postexposure, and by 24 hours postexposure, no viable virus was detected, with the geometric mean half-life being 0.90 hours (95% CI: 0.645–1.249).
SARS-CoV-2 displayed prolonged stability on those PPE materials evaluated in this study, all of which had infectious SARS-CoV-2 present at least 72 hours postexposure. A recent preprint reported virus recovery at 14 days postexposure on the plastic visor of the 3M Model BE-10L powered air-purifying respirators hood, and at 21 days postexposure on DuPont Tyvek 400 using stabilized virus containing mucin, bovine serum albumin, and tryptone, 15 whereas our study used virus in media. Although we found the predicted half-life of SARS-CoV-2 on PPE ranged from 6.74 to 10.05 hours (depending on the PPE material), it is important to note that between 1.9 and 2.3 log10 PFU/mL of infectious virus remained on those PPE evaluated in this study at 72 hours postexposure. This is in contrast to SARS-CoV-2 viability on cloth fabric (i.e., 50/50 nylon/cotton ripstop fabric), which decreased rapidly and was not recoverable at 24 hours postexposure, as reported elsewhere. 5,15
The results of this study should be interpreted in light of its limitations. Although the use of six-well tissue culture plates to hold exposed materials allowed air exchange, their use may have reduced virus desiccation. In addition, although exposed materials were not stored in darkness, continuous light was not always present. Similarly, the optical coating on the tissue culture plates and on the biosafety cabinet sash would have limited exposure to UV light reducing virus degradation. We exposed the materials in this study to a moderate dose of SARS-CoV-2 in 50 µL of media. Although certain high-risk airway procedures could result in such virus doses/volumes, most healthcare providers PPE would likely receive lower doses of SARS-CoV-2 while caring for COVID-19 patients. Thus, future work is needed to evaluate the stability of SARS-CoV-2 on PPE modeling transmission via infectious respiratory droplets (> 5 µm) and/or droplet nuclei (≤ 5 µm) in an effort to model the likelihood of fomite transmission via PPE contaminated in such a manner.
In summary, we demonstrated that SARS-CoV-2 remained infectious on some types of healthcare PPE for at least 72 hours postexposure at 22 ± 2°C following a moderate-dose exposure designed to mimic virus concentrations that might be achieved during high-risk airway procedures. Although our results highlight the stability of SARS-CoV-2 on PPE in an experimental setting, proper doffing and/or disposal or disinfection of PPE would reduce the likelihood of fomite transmission following such procedures.
The American Society of Tropical Medicine and Hygiene has waived the Open Access fee for this article due to the ongoing COVID-19 pandemic.
CDC , 2020. Scientific Brief: SARS-CoV-2 and Potential Airborne Transmission. Available at: https://www.cdc.gov/coronavirus/2019-ncov/more/scientific-brief-sars-cov-2.html. Accessed October 13, 2020.
Weissman DN , de Perio MA , Radonovich LJ Jr. , 2020. COVID-19 and risks posed to personnel during endotracheal intubation. JAMA 323: 2027–2028.
Feldman O , Meir M , Shavit D , Idelman R , Shavit I , 2020. Exposure to a surrogate measure of contamination from simulated patients by emergency department personnel wearing personal protective equipment. JAMA 323: 2091–2093.
Harbourt D , Haddow A , Piper A , Bloomfield H , Kearney BJ , Fetterer D , Gibson K , Minogue T , 2020. Modeling the stability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on skin, currency, and clothing. PLoS Negl Trop Dis 14: e0008831.
van Doremalen N et al. 2020. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 382: 1564–1567.
Chin AWH , Chu JTS , Perera MRA , Hui KPY , Yen HL , Chan MCW , Peiris M , Poon LLM , 2020. Stability of SARS-CoV-2 in different environmental conditions. Lancet Microbe 1: e10.
Biryukov J et al. 2020. Increasing temperature and relative humidity accelerates inactivation of SARS-CoV-2 on surfaces. mSphere 5: e00441-20.
Pastorino B , Touret F , Gilles M , de Lamballerie X , Charrel RN , 2020. Prolonged infectivity of SARS-CoV-2 in fomites. Emerg Infect Dis 26: 2256–2257.
Smither SJ , Eastaugh LS , Findlay JS , Lever MS , 2020. Experimental aerosol survival of SARS-CoV-2 in artificial saliva and tissue culture media at medium and high humidity. Emerg Microbes Infect 9: 1415–1417.
Haddow AD , Watt TR , Bloomfield HA , Shamblin JD , Dyer DN , Harbourt DE , 2020. Stability of SARS-CoV-2 on produce following a low-dose aerosol exposure. Am J Trop Med Hyg 103: 2024–2025.
Riddell S , Goldie S , Hill A , Eagles D , Drew TW , 2020. The effect of temperature on persistence of SARS-CoV-2 on common surfaces. Virol J 17: 145.
Matson MJ , Yinda CK , Seifert SN , Bushmaker T , Fischer RJ , van Doremalen N , Lloyd-Smith JO , Munster VJ , 2020. Effect of environmental conditions on SARS-CoV-2 stability in human nasal mucus and sputum. Emerg Infect Dis 26: 2276–2278.
Fischer RJ et al. 2020. Effectiveness of N95 respirator decontamination and reuse against SARS-CoV-2 virus. Emerg Infect Dis 26: 2253–2255.
Kasloff SB , Strong JE , Funk D , Cutts TA , 2020. Stability of SARS-CoV-2 on critical personal protective equipment. medRxiv. Available at: https://doi.org/10.1101/2020.06.11.20128884.